Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study

…, S Akuse, M Klebert, L Mitchell, D Nix… - Annals of internal …, 2021 - acpjournals.org
Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…

[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2

…, M Gergely, S Abushamma, M Klebert, L Mitchell, D Nix… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …

[HTML][HTML] Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients

CRC Zhang, D Nix, M Gregory, MA Ciorba… - Experimental …, 2019 - Elsevier
Highlights • Clonal hematopoiesis in ulcerative colitis patients is associated with an increased
incidence of DNMT3A and PPM1D mutations. • Elevated serum interferon γ in ulcerative …

Ambulatory reflux monitoring guides proton pump inhibitor discontinuation in patients with gastroesophageal reflux symptoms: a clinical trial

…, CP Gyawali, DA Carlson, PJ Kahrilas, BD Nix… - Gastroenterology, 2021 - Elsevier
Background and Aims Proton pump inhibitor (PPI) therapy fails to provide adequate
symptom control in up to 50% of patients with gastroesophageal reflux symptoms. Although a …

Optimal Wireless reflux monitoring metrics to predict discontinuation of proton pump inhibitor therapy

…, DA Carlson, PJ Kahrilas, BD Nix… - Official journal of the …, 2022 - journals.lww.com
METHODS: This single-arm clinical trial performed over 4 years at 2 centers enrolled adults
with troublesome GERD symptoms and inadequate response to> 8 weeks of PPI. …

Crohn's disease differentially affects region-specific composition and aerotolerance profiles of mucosally adherent bacteria

…, TS Sadiq, MJ Koruda, R Rahbar, BD Nix… - Inflammatory bowel …, 2020 - academic.oup.com
Background The intestinal microbiota play a key role in the onset, progression, and recurrence
of Crohn disease (CD). Most microbiome studies assay fecal material, which does not …

Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled …

…, T Walker, K Garza, L Chen, D Nix… - Crohn's & Colitis …, 2023 - academic.oup.com
Background and Aim Infliximab is typically given over an infusion time of 2 hours, leading to
a significant burden in inflammatory bowel disease (IBD) patients. We aimed to determine …

[HTML][HTML] First-in-Human Assessment of Gut Permeability in Crohn's Disease Patients Using Fluorophore Technology

LR Holtz, BD Nix, SE Akuse, C Hall-Moore… - Gastro Hep …, 2024 - Elsevier
Background and Aims The dual sugar absorption test (DSAT) as a classic measure of human
intestinal permeability has limited clinical utility due to lengthy and cumbersome urine …

[PDF][PDF] Please let us know how this document benefits you.

S Abushamma, T Walker, K Garza, L Chen, D Nix - digitalcommons.wustl.edu
Methods: Open-label randomized trial where IBD patients receiving maintenance infliximab
infusions were randomly assigned to 1-and 2-hour infusion groups, corresponding to study …

A theory of contemplation

JD Nix - arXiv preprint arXiv:1602.05705, 2016 - arxiv.org
In this paper you can explore the application of some notable Boolean-derived methods,
namely the Disjunctive Normal Form representation of logic table expansions, and extend them …